tipa-lauroyl sarcosinate은 임신 중 안전한가요?
Authoritative dossiers for lauroyl/sarcosinate category members (representative: sodium N‑lauroylsarcosinate) include an OECD 414 prenatal developmental study and long‑term reproductive/2‑year studies reporting no developmental/reproductive effects at doses up to and including high NOAELs; there is no harmonised CLP reproductive classification (ECHA registration dossiers show no H360/H361). PubMed/peer‑reviewed work on lauroyl sarcosinate does not identify reproductive/teratogenic effects. (Sources: ECHA registration dossiers; OECD414 summary in registration; PubMed literature.)
Pregnancy-safe products containing tipa-lauroyl sarcosinate
Related ingredients
Frequently asked questions
- tipa-lauroyl sarcosinate은 임신 중 안전한가요?
- Authoritative dossiers for lauroyl/sarcosinate category members (representative: sodium N‑lauroylsarcosinate) include an OECD 414 prenatal developmental study and long‑term reproductive/2‑year studies reporting no developmental/reproductive effects at doses up to and including high NOAELs; there is no harmonised CLP reproductive classification (ECHA registration dossiers show no H360/H361). PubMed/peer‑reviewed work on lauroyl sarcosinate does not identify reproductive/teratogenic effects. (Sources: ECHA registration dossiers; OECD414 summary in registration; PubMed literature.)
- tipa-lauroyl sarcosinate은 모유 수유 중 안전한가요?
- No evidence in registration dossiers or peer‑reviewed literature that lauroyl sarcosinates cause reproductive or lactation hazards or have mechanisms that would predict milk transfer or developmental toxicity. With topical cosmetic use (primarily rinse‑off surfactant), systemic exposure is expected to be negligible. (Sources: ECHA registration summaries; PubMed literature.)
- tipa-lauroyl sarcosinate은 아기 피부에 안전한가요?
- The ingredient is a mild anionic surfactant used in cleansers; authoritative safety dossiers for lauroyl sarcosinates support cosmetic use and do not indicate intrinsic developmental/reproductive hazard. For baby skin (0–3 yr) increase exposure score by +1 because infant skin has an immature barrier and higher surface‑area‑to‑weight, so low but measurable dermal absorption from rinse‑off/wash products is plausible even when adult systemic exposure is negligible. There is some consumer guidance and EWG notes about nitrosamine contamination risk for this class (cosmetic formulation/contaminant concern), but not reproductive toxicity. (Sources: ECHA registration summaries; CosIng/Cosmetic ingredient listings; EWG notes.)
- VeriMom은 tipa-lauroyl sarcosinate을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 tipa-lauroyl sarcosinate을 100/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 tipa-lauroyl sarcosinate 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.
